1) α-L- Fucosidase determination
α-L-岩藻糖苷酶测定
2) α-L-fucosidase
α-L-岩藻糖苷酶
1.
Clinical significance of determination of urine α-L-Fucosidase activity in patient with renal tubular injury;
尿α-L-岩藻糖苷酶活性测定对肾小管损伤的临床意义
2.
Localization of α-L-fucosidase within pig spermatozoa with special reference to its function in fertilization and sperm-oocyte interaction;
猪精子α-L-岩藻糖苷酶活性定位及其在精-卵结合及受精中的作用
3.
Evaluation on three reagents for determination of α-L-Fucosidase in serum;
3种测定血清α-L-岩藻糖苷酶试剂的评价
3) Alpha-fucosidase
α-L岩藻糖苷酶
1.
Objective To investigate the clinical value of tumor marker r-glutamyle transpeptidase(GGT),alpha-fucosidase (AFU) and alphafetoprotein(AFP) in the diagnose of PHC.
目的探讨肿瘤标志物谷氨酰转肽酶(GGT)、a-L岩藻糖苷酶(AFU)和甲胎蛋白(AFP)在原发性肝癌(PHC)诊断中的价值。
4) α-L-Fucosidase(AFU)
α-L-岩藻糖苷酶
1.
Measurement and significance of α-L-Fucosidase(AFU) in different weeks of pregnant women;
不同孕期孕妇血清α-L-岩藻糖苷酶(AFU)标准值研究测定及其对正常妊娠临床价值
2.
Objective To investigate the correlation between the activity of serum α-L-Fucosidase(AFU) and the non-cancerous lesion of the liver.
目的探讨血清α-L-岩藻糖苷酶(AFU)活性与非癌性肝脏损害程度的相关性。
3.
Objective To investigate the clinical significance of serum value HBV-preS1-Ag,adenosine deaminase(ADA)and α-L-Fucosidase(AFU) in hepatitisB viral(HBV) and the relationship between them and the degree of inflammation and the stage of fibre.
目的探讨乙型肝炎患者HBV前S1抗原(HBV preSl-Ag)、腺苷脱氨酶(ADA)及α-L-岩藻糖苷酶(AFU)的临床意义。
5) Alpha-L-fucosidase
α-L-岩藻糖苷酶
1.
Objective To investigate the clinical value of combined measurement of serum alpha-fetoprotein(AFP),alpha-L-fucosidase(AFU) and ferritin(SF) levels in the diagnosis of primary liver cancer.
目的:探讨血清甲胎蛋白(AFP)、α-L-岩藻糖苷酶(AFU)和铁蛋白(SF)联检对提高原发性肝癌阳性检出率的意义。
6) α L fucosidase
α-L-岩藻糖苷酶
1.
Objective: To study the complementary value of alpha fetoprotein (AFP), alpha fetoprotein variant and α L fucosidase to the diagnosis of primary hepatic cancer.
目的:探讨3种血清肿瘤标志物甲胎蛋白(AFP)、AFP异质体(AFP-L3)和α-L-岩藻糖苷酶(AFU)联合检测对原发性肝癌(PHC)的互补诊断价值及对肝癌早期诊断的意义。
补充资料：α-葡萄糖苷酶抑制剂
分子式：
CAS号：
性质：抑制一类结构中含有α-葡萄糖苷键水解的抑制剂，其中包括部分蔗糖酶、麦芽糖酶和淀粉酶抑制剂。其中阿卡糖是最重要的淀粉酶抑制剂，临床上用于治疗肥胖症和糖尿症。萃他丁是两形链霉菌产生的α-葡萄糖苷抑制剂，其母核与阿卡糖相同，仅多一个葡萄糖分子而已。属于这一类的抑制剂还有脂解素等结构与阿卡糖相似的链霉菌代谢产物。
CAS号：
性质：抑制一类结构中含有α-葡萄糖苷键水解的抑制剂，其中包括部分蔗糖酶、麦芽糖酶和淀粉酶抑制剂。其中阿卡糖是最重要的淀粉酶抑制剂，临床上用于治疗肥胖症和糖尿症。萃他丁是两形链霉菌产生的α-葡萄糖苷抑制剂，其母核与阿卡糖相同，仅多一个葡萄糖分子而已。属于这一类的抑制剂还有脂解素等结构与阿卡糖相似的链霉菌代谢产物。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条